US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioPharmX

0.5100

0.0000

Volume:- -

Turnover:- -

Market Cap:9.32M

PE:-0.68

High:0.5100

Open:0.5100

Low:0.5100

Close:0.5100

52wk High:1.18

52wk Low:0.2500

Shares:18.28M

Float Shares:16.07M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7497

EPS(LYR):-0.7497

ROE:-2020.23%

ROA:-209.33%

PB:13.00

PE(LYR):-0.68

Loading ...

Overview Company News Filings

Company Profile

Company Name:

BioPharmX

Exchange:

AMEX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.BioPharmX.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

BioPharmX Corporation, a specialty pharmaceutical company, develops products for the treatment of dermatologic conditions using its proprietary HyantX topical delivery system. Its clinical-stage product candidates include BPX01, a topical antibiotic gel that has completed Phase IIb clinical trials for the treatment of inflammatory lesions of acne; and BPX04, a topical antibiotic, which is in Phase IIb study for the treatment of inflammatory lesions of papulopustular rosacea. The company serves pharmaceutical companies, physician's practices, dermatologists, and general practitioners. BioPharmX Corporation is headquartered in Campbell, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BPMX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BPMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BPMX\",,,,,undefined,":{"symbol":"BPMX","market":"US","secType":"STK","nameCN":"BioPharmX","latestPrice":0.51,"timestamp":1589832000000,"preClose":0.51,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":16073891,"shares":18278219,"eps":-0.749709,"marketStatus":"Pre-Mkt","change":0,"latestTime":"02-18 05:51:46 EST","open":0.51,"high":0.51,"low":0.51,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.749709,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771425000000},"marketStatusCode":1,"symbolChange":{"newSymbol":"TMBR","executeDate":"2020-05-19"},"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"AMEX","adjPreClose":0.51,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BPMX\",,,,,undefined,":{"symbol":"BPMX","floatShares":16073891,"roa":"-209.33%","roe":"-2020.23%","lyrEps":-0.749709,"shares":18278219,"dividePrice":0,"high":0.51,"amplitude":0,"preClose":0.51,"low":0.51,"week52Low":0.25,"pbRate":"13.00","week52High":1.18,"institutionHeld":0,"latestPrice":0.51,"eps":-0.749709,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.749709,"open":0.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BPMX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-19","symbol":"BPMX","type":"split","dateTimestamp":1589860800000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2020-05-19","symbol":"BPMX","oldSymbol":"BPMX","newSymbol":"TMBR","exchange":"AMEX","type":"symbolChange","dateTimestamp":1589860800000},{"market":"US","date":"2020-04-30","symbol":"BPMX","fiscalQuarterEnding":"2020/01","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1588219200000,"reportTimeType":"","actualEps":-0.25},{"market":"US","date":"2019-12-10","symbol":"BPMX","fiscalQuarterEnding":"2019/10","expectedEps":-0.11,"name":null,"time":"","type":"earning","dateTimestamp":1575954000000,"reportTimeType":"","actualEps":-0.14},{"market":"US","date":"2019-09-09","symbol":"BPMX","fiscalQuarterEnding":"2019/07","expectedEps":-0.33,"name":null,"time":"","type":"earning","dateTimestamp":1568001600000,"reportTimeType":"","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BPMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BPMX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.BioPharmX.com","stockEarnings":[{"period":"1week","weight":-0.9167},{"period":"1month","weight":-0.9167},{"period":"3month","weight":-0.9167},{"period":"6month","weight":-0.9167},{"period":"1year","weight":-0.9167},{"period":"ytd","weight":-0.9167}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0127},{"period":"3month","weight":0.0305},{"period":"6month","weight":0.0744},{"period":"1year","weight":0.12},{"period":"ytd","weight":0.0014}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioPharmX Corporation, a specialty pharmaceutical company, develops products for the treatment of dermatologic conditions using its proprietary HyantX topical delivery system. Its clinical-stage product candidates include BPX01, a topical antibiotic gel that has completed Phase IIb clinical trials for the treatment of inflammatory lesions of acne; and BPX04, a topical antibiotic, which is in Phase IIb study for the treatment of inflammatory lesions of papulopustular rosacea. The company serves pharmaceutical companies, physician's practices, dermatologists, and general practitioners. BioPharmX Corporation is headquartered in Campbell, California.","exchange":"AMEX","name":"BioPharmX","nameEN":"BioPharmX"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BPMX\",market:\"US\",,,undefined,":null}}